Call to arrange a consultation
+1 416 777 0888
Search the site
Bayer Inc. et al v. Sandoz Canada Inc.
2025
T-243-25
Resolved
6(1) PM(NOC) Regulations
Application under subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations regarding aflibercept.
Counsel to:
Sandoz Canada Inc.
The decision is reported
here.
Meet the team.
.jpg)
.jpg)
%20(1).jpg)
